BluSmart, a Gensol customer and the entity sharing its co-founders, is implicated in an ongoing investigation by India’s Securities and Exchange Board (SEBI) into Gensol Engineering.

SEBI has suspended Gensol’s founders, Anmol Singh Jaggi and Puneet Singh Jaggi, from holding key roles in the company and participating in the securities market during the probe.

SEBI’s interim order claims the Jaggi brothers misused EV loan funds for personal expenses, including luxury real estate near Delhi.

The investigation centers on loans totaling 9.78 billion rupees (US$114 million) from Indian Renewable Energy Development Agency and Power Finance Corporation.

Of this, 6.63 billion rupees (US$77.38 million) were meant to buy 6,400 EVs for leasing to BluSmart. However, only 4,704 EVs were purchased for 5.68 billion rupees (US$66.3 million).

🔗 Source: TechCrunch

🧠 Food for thought

1️⃣ The capital-intensive fleet ownership model reveals fundamental challenges for EV ride-hailing

BluSmart’s difficulties expose the inherent vulnerability of owning electric vehicle fleets compared to traditional ride-sharing platforms.

Unlike Uber and Ola’s asset-light approach of using driver-owned vehicles, BluSmart’s ownership of its entire fleet requires massive upfront capital investment, creating significant financial pressure during downturns1.

This fleet ownership model, while initially praised for ensuring quality control and reliability, becomes particularly risky when combined with the higher upfront costs of electric vehicles.

The company’s current crisis has forced the sale of 3,000 EVs and reduced ride availability, directly impacting service quality and revenue potential2.

BluSmart’s experience demonstrates how capital-intensive business models in emerging sectors face elevated financial risks when scaling operations, especially when dependent on debt financing.

2️⃣ India’s corporate governance challenges persist despite regulatory framework

The SEBI investigation into Gensol Engineering illustrates continuing corporate governance weaknesses in India’s rapidly growing sectors, with regulators claiming the “promoters were running a listed public company as if it were a proprietary firm”3.

This case follows a pattern of similar corporate misconduct in India, echoing previous incidents like the Transgene Biotek fraud allegations of $38 million where funds were allegedly diverted for unauthorized purposes4.